Азитрокс

Quick links to important sections

Азитрокс

Selected form

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Азитрокс

What is Азитрокс?

Азитрокс is an antibacterial medication belonging to the macrolide group, specifically the subclass of azalides. It contains the active ingredient azithromycin, which is designed to inhibit the growth and spread of susceptible bacteria within the body.

Mechanism of Action

The medication works by interfering with the protein synthesis of bacterial cells. By binding to the 50S subunit of the bacterial ribosome, it prevents the translocation of peptides, effectively halting the production of essential proteins required for bacterial multiplication. Depending on the concentration at the site of infection and the specific type of pathogen, the drug can exert either bacteriostatic (growth-inhibiting) or bactericidal (bacteria-killing) effects.

Pharmacological Properties

Азитрокс is characterized by its ability to maintain high concentrations in tissues and cells. It is rapidly absorbed from the gastrointestinal tract and is transported by phagocytes directly to the site of inflammation. This targeted delivery allows the active substance to remain in the affected tissues for several days after the final dose has been administered.

Spectrum of Activity

This antimicrobial agent is effective against a broad range of microorganisms, including:

  • Gram-positive bacteria: Various species of Streptococcus and Staphylococcus.
  • Gram-negative bacteria: Including Haemophilus influenzae, Moraxella catarrhalis, and Bordetella pertussis.
  • Intracellular pathogens: Such as Chlamydia trachomatis, Mycoplasma pneumoniae, and Legionella pneumophila.
  • Anaerobic organisms: Certain types of Clostridium and Peptostreptococcus.

Because of its chemical structure, the medication is stable in acidic environments, which facilitates its transit through the stomach and subsequent absorption in the small intestine.

Regulatory References

  1. Azithromycin Mechanism of Action - NIH StatPearls

What side effects are possible with Азитрокс?

Possible Side Effects and Safety Information

The official safety information for Azithromycin (Азитрокс) is organized based on how frequently adverse reactions appeared in clinical reports and which body systems are affected, according to government regulatory standards. The medicine's risk profile is formally structured around documented common reactions and the identification of rare, serious events.

Official Adverse Reactions Scope

Category Description
Common Effects Reactions observed frequently include Gastrointestinal disorders such as nausea, vomiting, abdominal pain, and diarrhea. Headache is also classified as common.
Uncommon / Rare Effects Less frequent effects include dizziness, palpitations, and hepatitis. Rare but serious events include Torsades de Pointes (a type of irregular heart rhythm), hepatic failure, and severe skin reactions like Stevens-Johnson Syndrome (SJS).
Serious Adverse Reactions Regulatory documents explicitly list the risk of QT interval prolongation in the heart and potentially fatal hepatotoxicity. Furthermore, C. difficile-associated diarrhea (CDAD) is documented as a serious risk with this antibiotic.

Regulatory Safety Constraints

The medicine is officially contraindicated in individuals with a known history of hypersensitivity to Azithromycin or any macrolide antibiotic. Specific safety considerations apply to certain patients: it is generally contraindicated in those with a history of cholestatic jaundice or hepatic dysfunction associated with prior Azithromycin use. Caution is officially advised for patients with existing risk factors for QT prolongation and those with severe renal impairment. The exacerbation of Myasthenia Gravis symptoms is also a documented safety consideration.

This structure ensures all known risks, from common digestive issues to rare cardiac and liver problems, are formally communicated in a neutral, medically grounded context.

Overdose and Emergency Response

Overdose and when to seek help

Overdosage of Azithromycin has been officially documented to result in an exacerbation of common gastrointestinal adverse effects. These manifestations, often reported in higher than recommended doses, typically include nausea, vomiting, diarrhea, and abdominal pain. Regulatory documents note that skin rashes may also occur.

However, the primary concern documented by regulatory authorities involves severe, potentially life-threatening outcomes. These serious manifestations include the Prolongation of the QT interval, which carries a specific risk of developing Torsades de pointes, a form of potentially fatal cardiac arrhythmia. Additionally, severe overexposure has been linked to hepatic necrosis and hepatic failure. An increased risk of severe ventricular arrhythmia is officially noted for elderly patients and women.

Required Emergency Actions

Due to the official risk of severe cardiac events, urgent medical attention is required immediately if Azithromycin overdosage is suspected. Because no specific antidote is known, management focuses on procedural steps, including the administration of medicinal charcoal, general symptomatic treatment, and other supportive measures as required. A longer period of observation and treatment is often necessary due to the drug's extended half-life.

Therapeutic Uses of Азитрокс

What Азитрокс Treats: Main Uses and Benefits

Azithromycin is commonly applied in addressing conditions involving certain bacterial infections across several systems. This medication is relevant in clinical settings that involve acute or unstable symptom patterns from infections of the respiratory tract (including bacterial pneumonia and acute bronchitis exacerbations), ear and sinuses, uncomplicated skin tissues, and certain conditions involving inflammatory or irritative processes, such as specific sexually transmitted infections (STIs).

This medication is commonly used when short-term symptomatic assistance is needed. It is relevant for easing symptom clusters that may become intense or disruptive, such as symptoms related to systemic imbalance (fever) and symptoms related to physical discomfort (persistent cough, sore throat, earache, and painful urination).

This short-term symptomatic assistance supports general well-being during symptomatic phases and assists with maintaining functional stability when symptoms interfere with routine activities.

It is relevant for managing symptoms that interfere with daily comfort, providing support that assists with maintaining functional stability and contributes to easing the overall symptom load during periods of heightened discomfort.


Quick Fact: Relief for Acute Symptom Clusters Azithromycin is relevant for managing conditions characterized by periods of heightened symptoms that interfere with daily comfort, providing supportive relief across respiratory, dermatological, and genitourinary domains.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Азитрокс (Azithromycin) is subject to specific population eligibility rules defined by regulatory authorities. The medicine is contraindicated (must not be used) in patients with a known history of hypersensitivity to azithromycin, erythromycin, or any macrolide/ketolide antibiotic. Use is also prohibited in individuals with a history of cholestatic jaundice or hepatic dysfunction associated with prior azithromycin therapy.

Eligibility Domain Regulatory Constraint
Age Safety and effectiveness are not established for infants under six months of age. Caution is advised for neonates (up to 42 days old) and older adults due to specific risks.
Organ Function Use is generally not recommended in patients with severe hepatic impairment and requires caution in cases of severe renal impairment (< 10 mL/min).
Comorbidity The medicine must be used with caution in patients with conditions such as known QT prolongation or Myasthenia Gravis.
Reproductive Status Use during pregnancy and lactation is conditional, requiring a clinical assessment where the benefit must outweigh the potential risk.

Eligibility is also restricted in patients with severe pneumonia risk factors, as oral therapy may be deemed inappropriate.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation identifies specific patterns of interaction between Azithromycin and co-administered substances, primarily concerning effects on cardiac rhythm and drug exposure.

Documented Interaction Restrictions

Classification Interacting Substance Official Regulatory Statement
Contraindicated Combination Ergot Derivatives (e.g., Ergotamine) Co-administration is formally prohibited due to the theoretical risk of ergotism, a serious systemic toxicity documented with other macrolide antibiotics.
Increased Cardiac Risk QT-Prolonging Drugs Co-administration increases the risk of developing cardiac arrhythmia, specifically Torsades de Pointes, due to additive effects on the cardiac QT interval.

Pharmacokinetic and Monitoring Requirements

Azithromycin exhibits a low potential for interaction via the hepatic cytochrome P450 system. However, specific pharmacokinetic constraints are documented:

  • Nelfinavir (HIV Protease Inhibitor) significantly increases Azithromycin plasma concentration ( C max and AUC), mandating close monitoring for adverse reactions.
  • Antacids (Aluminum/Magnesium) taken simultaneously reduce the peak concentration ( C max) of Azithromycin, requiring administration to be separated by at least one to two hours.
  • Coumarin-type Oral Anticoagulants (e.g., Warfarin) may result in potentiated anticoagulation, requiring the mandatory monitoring of PT/ INR.
  • The Oral Suspension dosage form requires special attention, as food increases its C max by 56%, a concentration effect not seen with the tablet form.

Mechanism of Action

Inhibition of Bacterial Protein Synthesis

The primary mechanism of Azithromycin involves binding specifically to the 23S ribosomal RNA within the 50S ribosomal subunit of susceptible bacteria. This interaction physically impedes the movement of the nascent polypeptide chain, thereby blocking the process of protein synthesis. The resulting bacteriostatic effect halts the pathogen's ability to grow and replicate, supporting the host's immune clearance processes by managing a non-replicating pathogen population.

Modulation of Host Inflammatory Pathways

Beyond its antimicrobial action, Azithromycin accumulates in host immune cells and acts as a modulator of inflammation. The drug suppresses the key transcription factor NF-kappaB and inhibits the enzyme cPLA2, resulting in a decreased production and release of pro-inflammatory cytokines (like IL-8) and mediators. This secondary mechanism limits the pathological accumulation of inflammatory cells (such as neutrophils), reducing the influx of inflammatory cells and modulating the cytokine response, which contributes to the attenuation of tissue inflammation.

Limitations Due to Resistance Mechanisms

The drug's inhibitory mechanism is constrained when bacterial resistance develops through specific molecular changes. The primary limitations occur when the bacterial target site (23S rRNA) is chemically modified (methylated) or when efflux pumps are over-expressed. Both mechanisms prevent the drug from achieving or maintaining the concentration necessary to block the ribosome, resulting in the loss of inhibitory activity.

Dosage and Administration Information

How to Use Azithromycin (Азитрокс): Official Administration Guidelines

Azithromycin is administered via the oral route, using tablets or suspensions, and, in acute hospital settings, by intravenous (IV) infusion. The oral forms are designed for once-daily administration over short, defined treatment periods, typically three or five days.


Standard Dosage Regimens (Adults)

Official dosing is generally based on the total amount of medicine given over a course, most often 1500 mg.

Regimen Dose Pattern Frequency & Duration
3-Day Course 500 mg once daily For 3 consecutive days
5-Day Course 500 mg on Day 1, then 250 mg on Days 2–5 Once daily for 5 days
Single-Dose 1000 mg (1 g) or 2000 mg (2 g) As a single oral dose for specific conditions

Administration Conditions and Preparation

The film-coated tablets and standard oral suspension may be taken with or without food. Taking the dose immediately before a meal may help enhance gastrointestinal tolerability.

For Intravenous (IV) use, Azithromycin is supplied as a powder that must be reconstituted and then diluted into an appropriate solution (e.g., Normal Saline) by a healthcare professional. The final solution must be infused slowly over a minimum duration, such as one hour or three hours, and must not be administered as a rapid injection or bolus.

If an oral dose is missed, it is generally advised to take the dose immediately if it is 12 hours or less after the scheduled time, and then resuming the original daily schedule. If more than 12 hours have passed, the missed dose should be skipped, and the patient should wait for the next regularly scheduled dose.

Population-Specific Dosing

Pediatric dosing (for children weighing less than 45 kg) relies on the oral suspension form, with doses calculated based on body weight (e.g., 10 mg/kg once daily for 3 days). No dose adjustment is generally required for older adults or in cases of mild to moderate renal or hepatic impairment.

Recent Clinical Evidence

Азитрокс: Overview of Clinical Studies

Evidence for Acute Infections

Research was studied for its use in conditions such as community-acquired pneumonia (CAP) and acute exacerbations of chronic bronchitis (AECB) through short-term Randomized Controlled Trials (RCTs). Studies focused on outcomes related to clinical success metrics and the measured microbiological eradication of specific bacterial pathogens. Findings describe patterns related to how clinical response was measured in patients suitable for oral therapy.

Azithromycin was studied for Acute Otitis Media (AOM), bacterial sinusitis, uncomplicated skin infections, and specific sexually transmitted infections (STIs). Clinical trials explored these conditions, often involving comparisons to other evaluated therapies. Researchers focused on measuring clinical cure rates and pathogen elimination. Research describes patterns related to measured microbiological cure rates for susceptible infections. Some studies documented variability in outcomes concerning the eradication of certain pathogens, and the data for efficacy in certain female subpopulations with genital ulcer diseases remain insufficient due to limited trial size.

Long-Term Research and Uncertainties

A distinct body of research was evaluated in long-term evaluated regimens for chronic respiratory conditions like Cystic Fibrosis (CF) and Non-CF Bronchiectasis, with follow-up periods extending up to 18 months or more. Researchers examined outcomes related to lung function metrics and the frequency of pulmonary exacerbations.

The evidence base includes studies for Pediatric patients (starting at 6 months of age) in acute infections, though evidence for older adults and pregnant women remains limited. Research documents the potential for developing macrolide resistance following long-term use, and notes that the durability of any patterns observed after the study period is not clearly defined. Ultimately, long-term effects are not fully established across most indications, and evidence quality varies across studies.

Frequently Asked Questions (FAQ)

Common questions about Азитрокс (FAQ)


Q: Why is Азитрокс sometimes called a 'Z-Pak'?

“Z-Pak” is a common trade name used for the commercial packaging of azithromycin in some regions. This term typically refers to a specific pre-packaged regimen that contains the full short-term course of the medicine.


Q: How quickly does Азитрокс usually start working?

Improvement in symptoms is generally expected to begin within the first few days of treatment. The medicine is not expected to work faster than other antibiotics that are dosed over a longer period.


Q: Can Азитрокс treat all types of infections?

Azithromycin is classified as an antibacterial drug, meaning it is intended only to treat infections caused by susceptible bacteria. It is not effective against viral infections, such as the common cold or flu.


Q: Is it common to feel tired while taking Азитрокс?

Tiredness or fatigue is generally reported in official documentation as an uncommon side effect. This means that while some patients experience it, it occurs only in a small percentage of cases during treatment.


Q: Are there specific food items to avoid when taking Азитрокс?

Regulatory information states that azithromycin tablets and standard oral suspension can generally be taken with or without food. This method of administration has been described in official materials as potentially enhancing gastrointestinal tolerability.


Q: Does alcohol interact with Азитрокс?

Official information indicates that there are no known interactions specifically documented between azithromycin and alcohol.


Q: Does Азитрокс interact with birth control pills?

Studies and regulatory notes suggest that azithromycin may potentially reduce the effects of ethinyl estradiol, which is an active ingredient found in some oral contraceptives.


Q: Is there a link between Азитрокс and heart rhythm problems?

Official safety constraints note that azithromycin is associated with the risk of QT interval prolongation, which is a change in the heart’s electrical rhythm. This effect carries a rare but serious risk of fatal cardiac arrhythmias, such as Torsade de Pointes.


Q: Why is sun sensitivity sometimes mentioned with Азитрокс?

The medicine can sometimes cause photosensitivity, meaning it makes the skin more sensitive to the sun. This increased sensitivity is documented in patient information.


Q: Does Азитрокс interact with common pain relievers like ibuprofen or acetaminophen?

Regulatory checks indicate that no interactions were found between azithromycin and the common pain reliever ibuprofen.


Q: Is it true that Азитрокс stays in the body for a long time?

Yes, azithromycin is known to have a long elimination half-life, approximately 68 hours. This prolonged duration is due to the medicine being extensively taken up and then slowly released from body tissues.


Q: Is a metallic taste in the mouth reported as a side effect of Азитрокс?

Official lists of adverse effects include changes in taste and smell as a less common side effect. This sometimes results in patients reporting a metallic taste in the mouth or a temporary loss of taste.


Q: How does Азитрокс compare to other antibiotics in terms of side effect profiles?

Because azithromycin belongs to the macrolide class, its side-effect profile is distinct from other antibiotic groups. For example, it is not associated with the same significant kidney (nephrotoxic) or ear (ototoxic) effects often seen with the aminoglycoside class.


Q: Is it possible to become resistant to Азитрокс?

Yes, the risk of developing antimicrobial resistance is a known safety consideration associated with the use of azithromycin. Official guidance notes that the risk of resistance is a factor considered when assessing the appropriate use of the drug.


Q: Can Азитрокс be used for skin infections?

Official information indicates that azithromycin is approved for the treatment of certain types of skin infections when they are caused by bacteria that are susceptible to the medicine.


Q: Do official sources mention any long-term effects of using Азитрокс?

The FDA has issued safety warnings regarding a specific investigational use of long-term azithromycin in a highly specific patient population (post-stem cell transplant). This warning noted an increased rate of cancer relapse and death in that group when the drug was used long-term for prevention.


Q: Can men and women use Азитрокс similarly?

Clinical studies show similar efficacy in men and women for many indications. However, official documents note that the risk of drug-induced arrhythmias, such as Torsade de Pointes, is generally reported more often in women than in men.


Q: Can Азитрокс cause yeast infections?

Yes, like other antibiotics that target bacterial growth, azithromycin use is associated with the potential to disrupt the body’s normal balance of microorganisms, which may lead to a fungal infection such as thrush (a yeast infection).


Q: Is it known to affect blood sugar levels?

Some observations suggest that there may be a slight fluctuation in blood sugar levels when azithromycin is taken. These levels are typically reported to return to a normal range following the period of use.


Q: What are the signs of an allergic reaction to look out for?

Signs of a potentially serious allergic reaction can include developing a spreading skin rash, having trouble breathing, or noticing swelling of the face or throat. These signs are considered medical emergencies and require prompt attention.


Q: Does Азитрокс help with viral infections?

Azithromycin is an antibacterial drug that treats only bacterial infections. It is not effective against viral infections, and regulatory information specifically states it should not be used to treat conditions like the common cold.


Q: Is it normal if I don't feel better immediately after the first dose of Азитрокс?

Feeling improvement immediately after the first dose is not typically expected. While symptom improvement is generally anticipated within the first few days of treatment, clinical use guidelines are based on completing the entire course.


Q: Does Азитрокс have different names in other countries?

Yes, the active ingredient is globally recognized as Azithromycin, but it is sold under various trade names in different regions. Examples of these trade names include 'Zithromax' and 'Z-Pak' in some countries.


Q: Are allergic reactions to Азитрокс common?

Allergic reactions (hypersensitivity) to macrolide antibiotics like azithromycin are generally considered infrequent. Available data suggests they occur only in a small percentage of reported cases.


Q: What is the general expectation for improvement after starting Азитрокс?

The general expectation is that a patient will begin to notice improvement in their symptoms within the first few days of starting treatment. Clinical use guidelines are based on completing the entire course.

How should Азитрокс be stored and disposed of?

Storage Requirements

Formulation Required Storage Condition Stability/Handling Rule
Tablets / Dry Powder Controlled room temperature (59 F to 86 F / 15 C to 30 C) Keep in original, tightly closed container; protect from moisture and excessive heat.
Constituted Suspension Room temperature or refrigeration (41 F to 86 F / 5 C to 30 C) Do not freeze; discard after 10 days.
Extended-Release Suspension Store at room temperature Do not refrigerate or freeze; discard after 12 hours.

All forms of this medicine must be kept out of the sight and reach of children by using locked safety caps.

Disposal

Any unused or expired Azithromycin must be safely thrown away. The official guidance requires mixing the medicine (without crushing) with an undesirable substance before discarding it in the household trash. The product must not be flushed down a toilet or sink to prevent environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Азитрокс found in:

A-Z Index: